B-cell targeting: a novel approach to immune intervention today and tomorrow. - Wikidata - wikimedia - TriplyDB

B-cell targeting: a novel approach to immune intervention today and tomorrow.

B-cell targeting: a novel approach to immune intervention today and tomorrow.

http://www.wikidata.org/entity/Q36922233

about

CD20 deficiency in humans results in impaired T cell-independent antibody responses Ocrelizumab: a step forward in the evolution of B-cell therapy Efficacy and safety of epratuzumab in patients with moderate/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study Intensive pharmacological immunosuppression allows for repetitive liver gene transfer with recombinant adenovirus in nonhuman primates Epstein-Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment.Improved therapeutic results by pretargeted radioimmunotherapy of non-Hodgkin's lymphoma with a new recombinant, trivalent, anti-CD20, bispecific antibody.Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity.Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma.Response of patients with refractory myasthenia gravis to rituximab: a retrospective study.Epstein-Barr virus infection transforms CD25+ B cells into antibody-secreting cells in rheumatoid arthritis patients.

P2860

Q24653638-08515141-2D6A-430A-8A1C-4D8720BB65F8 Q28245986-46FFB35C-AA71-4A73-B40F-63FFA09DA3C6 Q28660706-100CA1E1-5B5F-4CBF-BEB3-99361E9EB24F Q33822191-EDB2B205-C8B2-43D4-B923-E49AA77F3AA3 Q34117122-EB0735F3-2FA6-425D-ABA7-2186468A13D6 Q36979699-67F8DF7E-14FB-465D-8170-7A1AB4E67359 Q37072801-6758D72A-05A4-4C35-8439-DBB66C760CAE Q37884384-AAECED8F-8CF2-489B-9B92-580B9FAC2548 Q38633453-92A98DC4-DD11-4E36-BBE1-594F3F27AB06 Q42284576-7471626C-4816-4C53-BD63-FC61E448AB01

P2860

B-cell targeting: a novel approach to immune intervention today and tomorrow.

http://www.wikidata.org/entity/Q36922233

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

B-cell targeting: a novel approach to immune intervention today and tomorrow.

@en

type

label

B-cell targeting: a novel approach to immune intervention today and tomorrow.

@en

prefLabel

B-cell targeting: a novel approach to immune intervention today and tomorrow.

@en

P1433

Q36922233-A429A540-C846-4A26-BF3D-1516A5516876

P1476

Q36922233-5CAF525F-9D91-4C30-98AE-4A6253546EFD

P2093

Q36922233-0698133C-072B-4C37-AD15-5EED468F2DE4

Q36922233-E7F2CC3E-0337-416B-A521-BA8C46B73BAC

P2860

Q36922233-0091C8B8-647B-4A6F-9F8F-0DE716E462D3

Q36922233-036888E9-AD61-439E-B48F-81B198F2DDA6

Q36922233-058F481D-E4EC-4D55-B9B2-D1FD1F6E289E

Q36922233-0D0AA1CF-A04F-4477-87DB-54CD4A074CE3

Q36922233-0E86748B-4193-4099-BB02-04C84538D9AA

Q36922233-0F012EC7-A13D-44AE-9341-E6A1F629EA24

Q36922233-103242A5-58AC-4D37-B715-C88048D633B7

Q36922233-10C857DD-E007-4427-8056-B781235FC524

Q36922233-11101DA7-507A-49AA-BD48-85C9E731FBA9

Q36922233-12988313-090E-4330-9052-B0F6F648805B

P304

Q36922233-4C257DF9-AB5A-4602-87D7-B07F56A191E8

P31

Q36922233-A818D2AE-4720-44A8-8EA0-C52B94C01378

P356

Q36922233-3EC58E03-4D2E-42C0-9732-FDBE3F0C0D5D

P407

Q36922233-D24C28FC-F331-43C3-87E5-99017049112B

P433

Q36922233-A114456C-3B3D-4A3B-A4C2-10BC53648FCD

P478

Q36922233-9148B9E3-01DF-4003-ABB1-14059547EE15

P577

Q36922233-F6237B00-FB8C-4AC1-A690-26B604BA9199

P698

Q36922233-79F9C000-B2D4-49A9-92A8-C4DD6F1F8B29

P356

14712598.7.9.1287

P1433

Expert Opinion on Biological Therapy

P1476

B-cell targeting: a novel approach to immune intervention today and tomorrow.

@en

P2093

Peter E Lipsky

http://www.w3.org/2001/XMLSchema#string

Thomas Dörner

http://www.w3.org/2001/XMLSchema#string

P2860

Systemic lupus erythematosus and the type I interferon system

Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus

Involvement of inducible costimulator-B7 homologous protein costimulatory pathway in murine lupus nephritis

Autoreactivity by design: innate B and T lymphocytes

Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma

Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6

Fcgamma receptors: old friends and new family members

A soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeys

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

BCMA is essential for the survival of long-lived bone marrow plasma cells

P304

1287-1299

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.7.9.1287

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17727320

http://www.w3.org/2001/XMLSchema#string